The MLSC is proud to sponsor Mass General Brigham (MGB) Springboard Studio’s Design Impact Awards Demo Day, featuring creative problem‑solvers from across MGB working to make healthcare more user-friendly for...
Tufts University, in partnership with LabCentral, invites you to Tufts in Translation: A Faculty Speaker Series — spotlighting early-stage discoveries with strong translational relevance. CNS drug development continues to struggle with...
Join over 2,900 life sciences, biotech, and healthcare IT leaders for the 25th annual Bio‑IT World Conference & Expo, the premier global event accelerating precision medicine through technology and data....
Join America’s leading rare disease and orphan drug event in Boston! The World Orphan Drug Congress is an award-winning series of conferences and exhibitions that have grown to become the...
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events and provides this content and information as a convenience to visitors to the MLSC website.
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.
